Generic Sweden Dirección

Dirección controles de criterios 4/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Jonas Jegerborn

Chief Executive Officer (CEO)

kr2.8m

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	no data
Participación del CEO	1.5%
Permanencia media de la dirección	4.9yrs
Promedio de permanencia en la Junta Directiva	7yrs

Actualizaciones recientes de la dirección

Should You Take Comfort From Insider Transactions At Generic Sweden AB (STO:GENI)?

Feb 14

Recent updates

We Ran A Stock Scan For Earnings Growth And Generic Sweden (STO:GENI) Passed With Ease

Aug 26

A Look At The Intrinsic Value Of Generic Sweden AB (STO:GENI)

Apr 28

Is It Time To Consider Buying Generic Sweden AB (STO:GENI)?

Apr 08

Is Now The Time To Put Generic Sweden (STO:GENI) On Your Watchlist?

Feb 18

Calculating The Fair Value Of Generic Sweden AB (STO:GENI)

Jan 10

With EPS Growth And More, Generic Sweden (STO:GENI) Is Interesting

Nov 08

Here's Why I Think Generic Sweden (STO:GENI) Is An Interesting Stock

Jul 17

Here's Why I Think Generic Sweden (STO:GENI) Might Deserve Your Attention Today

Apr 13

Is Generic Sweden AB (STO:GENI) A Smart Pick For Income Investors?

Mar 26

A Look At The Intrinsic Value Of Generic Sweden AB (STO:GENI)

Mar 04

Should You Take Comfort From Insider Transactions At Generic Sweden AB (STO:GENI)?

Feb 14

Will Weakness in Generic Sweden AB's (STO:GENI) Stock Prove Temporary Given Strong Fundamentals?

Jan 26

Here's Why I Think Generic Sweden (STO:GENI) Might Deserve Your Attention Today

Jan 05

Is There More To The Story Than Generic Sweden's (STO:GENI) Earnings Growth?

Dec 16

Does Generic Sweden AB (STO:GENI) Have A Place In Your Dividend Portfolio?

Nov 25

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Jonas Jegerborn en comparación con los beneficios de Generic Sweden?
Fecha	Compensación total	Salario	Ingresos de la empresa
Dec 31 2023	n/a	n/a	kr23m
Sep 30 2023	n/a	n/a	kr24m
Jun 30 2023	n/a	n/a	kr23m
Mar 31 2023	n/a	n/a	kr21m
Dec 31 2022	kr3m	n/a	kr20m
Sep 30 2022	n/a	n/a	kr19m
Jun 30 2022	n/a	n/a	kr18m
Mar 31 2022	n/a	n/a	kr19m
Dec 31 2021	kr3m	n/a	kr18m
Sep 30 2021	n/a	n/a	kr17m
Jun 30 2021	n/a	n/a	kr15m
Mar 31 2021	n/a	n/a	kr13m
Dec 31 2020	kr3m	n/a	kr11m
Sep 30 2020	n/a	n/a	kr10m
Jun 30 2020	n/a	n/a	kr10m
Mar 31 2020	n/a	n/a	kr9m
Dec 31 2019	kr2m	kr1m	kr9m

Compensación vs. Mercado: La compensación total ($USD254.53K) de Jonas está en línea con el promedio de empresas de tamaño similar en el mercado Swedish ($USD239.43K).

Compensación vs. Ingresos: La compensación de Jonas ha sido consistente con los resultados de la empresa en el último año.

CEO

Jonas Jegerborn (51 yo)

no data

Permanencia

kr2,769,000

Compensación

Mr. Jonas Jegerborn serves as the Chief Executive Officer and President at Generic Sweden AB.

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Jonas Jegerborn	President & CEO	no data	kr2.77m	1.47% SEK 9.3m
Susanne Lundin	Chief Financial Officer	3.3yrs	sin datos	sin datos
Magnus Rasmusson	Chief Technology Officer	4.4yrs	sin datos	sin datos
Gustav Molander	Sales Director	5.4yrs	sin datos	sin datos
Madelene Persson	Marketing Manager	5.3yrs	sin datos	sin datos

4.9yrs

Permanencia media

45yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de GENI se considera experimentado (4.8 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Kenth-Ake Jonsson	Independent Director	15yrs	kr75.00k	sin datos
Bengt-Arne Molin	Independent Director	4yrs	kr75.00k	sin datos
Hans Krantz	Chairman of the Board	14.5yrs	kr150.00k	21.82% SEK 137.3m
Stefan Widen	Independent Director	10yrs	kr75.00k	sin datos
Johanna Berlinde	Independent Director	less than a year	sin datos	sin datos
Erik Ivarsson	Director	2yrs	sin datos	sin datos

7.0yrs

Permanencia media

64.5yo

Promedio de edad

Junta con experiencia: La junta directiva de GENI se considera experimentada (6.9 años de antigüedad promedio).

Generic Sweden Dirección

Dirección controles de criterios 4/4

Información clave

Actualizaciones recientes de la dirección

Less than half of directors are independent

Owner & Member of the board recently sold kr3.5m worth of stock

Owner & Member of the board recently sold kr3.1m worth of stock

Owner & Member of the board recently sold kr1.4m worth of stock

Owner & Member of the board recently sold kr1.3m worth of stock

Should You Take Comfort From Insider Transactions At Generic Sweden AB (STO:GENI)?

Recent updates

Upcoming dividend of kr1.50 per share

Now 23% undervalued after recent price drop

Some Confidence Is Lacking In Generic Sweden AB (STO:GENI) As Shares Slide 29%

Generic Sweden's (STO:GENI) Solid Earnings May Rest On Weak Foundations

Do Generic Sweden's (STO:GENI) Earnings Warrant Your Attention?

Full year 2023 earnings: EPS misses analyst expectations

Investor sentiment deteriorates as stock falls 16%

Now 25% undervalued

Should You Investigate Generic Sweden AB (STO:GENI) At kr60.20?

Investor sentiment improves as stock rises 16%

Now 22% undervalued

Third quarter 2023 earnings: Revenues exceed analyst expectations

Investor sentiment improves as stock rises 21%

Is Now The Time To Look At Buying Generic Sweden AB (STO:GENI)?

New major risk - Earnings quality

Investor sentiment improves as stock rises 17%

Should You Be Adding Generic Sweden (STO:GENI) To Your Watchlist Today?

Upcoming dividend of kr1.25 per share at 2.9% yield

Full year 2022 earnings: EPS exceeds analyst expectations

Investor sentiment improves as stock rises 21%

Full year 2022 earnings: EPS exceeds analyst expectations

Is Generic Sweden AB (STO:GENI) Potentially Undervalued?

Now 21% undervalued

Now 21% undervalued

Third quarter 2022 earnings: Revenues exceed analyst expectations

Investor sentiment improved over the past week

Second quarter 2022 earnings: Revenues miss analyst expectations

We Ran A Stock Scan For Earnings Growth And Generic Sweden (STO:GENI) Passed With Ease

Investor sentiment deteriorated over the past week

Now 23% undervalued after recent price drop

First quarter 2022 earnings: Revenues miss analyst expectations

Upcoming dividend of kr1.00 per share

A Look At The Intrinsic Value Of Generic Sweden AB (STO:GENI)

Less than half of directors are independent

Is It Time To Consider Buying Generic Sweden AB (STO:GENI)?

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Now 23% undervalued after recent price drop

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorated over the past week

Is Now The Time To Put Generic Sweden (STO:GENI) On Your Watchlist?

Investor sentiment improved over the past week

Calculating The Fair Value Of Generic Sweden AB (STO:GENI)

Investor sentiment deteriorated over the past week

Owner & Member of the board recently sold kr3.5m worth of stock

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Owner & Member of the board recently sold kr3.1m worth of stock

Third quarter 2021 earnings released

With EPS Growth And More, Generic Sweden (STO:GENI) Is Interesting

Investor sentiment deteriorated over the past week

Second quarter 2021 earnings released

Investor sentiment improved over the past week

Here's Why I Think Generic Sweden (STO:GENI) Is An Interesting Stock

Owner & Member of the board recently sold kr1.4m worth of stock

Owner & Member of the board recently sold kr1.3m worth of stock

Investor sentiment improved over the past week

First quarter 2021 earnings released

Upcoming dividend of kr0.80 per share

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Here's Why I Think Generic Sweden (STO:GENI) Might Deserve Your Attention Today

Is Generic Sweden AB (STO:GENI) A Smart Pick For Income Investors?

A Look At The Intrinsic Value Of Generic Sweden AB (STO:GENI)

Should You Take Comfort From Insider Transactions At Generic Sweden AB (STO:GENI)?

Will Weakness in Generic Sweden AB's (STO:GENI) Stock Prove Temporary Given Strong Fundamentals?

Here's Why I Think Generic Sweden (STO:GENI) Might Deserve Your Attention Today

Is There More To The Story Than Generic Sweden's (STO:GENI) Earnings Growth?